P1.01-050 Overall Survival in Advanced Lung Cancer Patients Treated at Oncosalud-AUNA
نویسندگان
چکیده
منابع مشابه
Urban vs. rural patients. Differences in stage and overall survival among patients treated surgically for lung cancer.
INTRODUCTION Besides the undoubted influence of risk factors on morbidity and survival time, there are also other environmental factors, such as awareness of the prevalence of risk factors and the availability of modern diagnosis and treatment methods. OBJECTIVE To evaluate differences in lung cancer 5-year overall survival rates between urban and rural patients hospitalized in the Department...
متن کاملSurvival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
This survival analysis was conducted at Ubon Ratchathani Cancer Center to determine the prognostic factors for survival of patients with stage IIIA, stage IIIB, and stage IV non-small-cell lung cancer (NSCLC) patients treated at the center between 1997-2001. The study sample included 210 patients with non-small-cell lung cancer. Diagnosis and staging were defined employing the TNM system. The m...
متن کاملRisk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated wi
Primary androgen deprivation therapy (PADT) has played an important role in the treatment of prostate cancer. We sought to identify factors of PSA progression in our series of patients with localized and locally advanced prostate cancer treated with PADT. Six-hundred forty-nine patients with localized and locally advanced prostate cancer who received PADT from 1998 to 2005 by Nara Uro-Oncology ...
متن کاملProlongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody.
PURPOSE The cancer/testis antigen XAGE1 (GAGED2a) is expressed in approximately 40% of advanced lung adenocarcinomas. We investigated the clinical relevance of the XAGE1 (GAGED2a) immune responses in patients with advanced lung adenocarcinoma. EXPERIMENTAL DESIGN The XAGE1 (GAGED2a) antigen expression and EGFR mutation were determined with tumor tissues. The XAGE1 (GAGED2a) antibody and T-cel...
متن کاملCyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
OBJECTIVE Sorafenib is a recommended treatment for advanced hepatocellular carcinoma. The study is to evaluate the efficacy of sorafenib plus cyproheptadine compared with sorafenib alone in patients with advanced hepatocellular carcinoma. METHODS A retrospective cohort study reviewed all consecutive advanced hepatocellular carcinoma cases with Child-Pugh Class A disease starting sorafenib tre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2017
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2016.11.574